Excipients & Specialty Ingredients
Company Overview
About
Accela ChemBio is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:China
Founded:1998
Employees:2,431
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
North America
Regulatory Approvals
Drug Approval 6IXFW8
Health Canada · #APR-3JFC8UXC · 2022-08-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-1HUYXLZ5
Issued: 2020-09-17
Expires: 2025-04-13
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-AAN9CAHO
Issued: 2020-08-17
Expires: 2025-04-25
Loading CDMO intelligence...
Key facts about Accela ChemBio
- Accela ChemBio is headquartered in China.
- Accela ChemBio was founded in 1998.
- Accela ChemBio has 2,431 employees.
- Accela ChemBio's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Accela ChemBio
Directory pages this company appears in, each with the full list of matching manufacturers.